Fractyl Health, Inc. Stock Analysis & AI Score
Fractyl Health, Inc. (GUTS) has an ST Score of 32.8 (C-), driven by its Forecast (A) and held back by its Sentiment (F). Analysts rate it Buy with a $5.00 price target (+964.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Fractyl Health, Inc. (GUTS) has an ST Score of 32.8 (C-), driven by its Forecast (A) and held back by its Sentiment (F). Analysts rate it Buy with a $5.00 price target (+964.1% upside).
- Strongest
- ForecastA
- Weakest
- SentimentF
All factor grades
- ForecastA
- ValuationB-
- Financial StrengthC+
- GrowthC-
- MomentumD
- ProfitabilityF
- SentimentF
- Piotroski2/9
Contact
GUTS stock: frequently asked questions
What is GUTS's ST Score?
Fractyl Health, Inc. (GUTS) has an ST Score of 32.8 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GUTS a buy, hold, or sell?
Analysts rate GUTS a Buy, with a price target of $5.00 (+964.1% vs the current price). Our ST Score grades it C- (32.8/100). The ST Score is a data-driven signal, not a recommendation.
What are GUTS's factor grades?
Valuation B-, Profitability F, Financial Strength C+, Momentum D, Growth C-, Forecast A, Sentiment F.
What is GUTS's valuation grade?
Fractyl Health, Inc. (GUTS) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GUTS's growth grade?
Fractyl Health, Inc. (GUTS) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GUTS's profitability grade?
Fractyl Health, Inc. (GUTS) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GUTS's financial strength grade?
Fractyl Health, Inc. (GUTS) earns a financial strength grade of C+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GUTS?
The average analyst price target for Fractyl Health, Inc. (GUTS) is $5.00 from 3 analysts, which is +964.1% versus the recent price of $0.47.
What is GUTS's Piotroski score?
Fractyl Health, Inc. (GUTS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.